LL-17-32
FKRIVQRIKDFLRNLV-acid
Description
Application Data
Description
-
Anti-microbial domain of LL-37 peptide.
Application Data
-
Catalogue number crb1000036 Molecular Weight 2044.2 Sequence (one letter code) FKRIVQRIKDFLRNLV-acid
Sequence (three letter code) H-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-OH
Purity >95% Storage - 20 ° C References Cox et al (2003) Susceptibility of Treponema pallidum to host-derived antimicrobial peptides. Peptides. 24 1741 PMID: 15019205
Singh et al (2014) LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH. J. Biol. Chem. 289(40) 27614 PMID: 25092290
Tripathi et al (2014) LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 96(5) 931 PMID: 25082153
Manufactured in: United Kingdom This peptide represents the anti-microbial domain of the LL-37 peptide.
LL-37 is a member of the large cationic family of anti-microbial peptides called cathelicidins which have broad-spectrum anti-microbial activity and are expressed in many species. The only cathelicidin found in humans is LL-37; this is produced in epithelial cells, by proteolytic cleavage from the C-terminal of the hCAP-18 protein. LL-37 can be processed into different forms of anti-microbial peptides. As well as its anti-microbial properties LL-37 also has anti-cancer properties and regulates many aspects of the innate immune system; overexpression of LL-37 has been linked to autoimmune diseases such as asthma and psoriasis
LL-17-32
You may also like…
-
LL-17-29
FKRIVQRIKDFLR-acid
View products -
[5-FAM]-LL-37
[5-FAM]-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid
View products -
LL-37 acid
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid
View products -
LL-13-37
IGKEFKRIVQRIKDFLRNLVPRTES-acid
View products -
LL-37 fragment (30-34), LL30-34 HeavyNLVP-[U-13C6,15N4-Arg]-acid
View products -
LL-24-29 HeavyIKDFL-[U-13C6,15N4-Arg]-acid
View products